Sun Logo
Visionary medical Supplies, Inc.

SUTURES, IOLS, OPHTHALMIC SOLUTIONS, AND MORE

 

VisiVisc

Hydroxypropyl methylcellulose 2%

Premium quality viscoelastic solution

NOT AVAILABLE FOR SALE IN THE U.S.  CE Mark

  • Effective in the protection of corneal endothelium
  • Safer alternative to Sodium Hyaluronate
  • Non-antigenic & non-inflammatory
  • Consistent physical & chemical properties
  • Double sterilization to render contents sterile
  • Dual filtration to ensure fiber-free solution
DESCRIPTION

VisiVisc is a viscoelastic high molecular weight solution of a non-inflammatory, highly purified grade of hydroxypropyl methylcellulose 2%, clear, isotonic, sterile and non-pyrogenic for intraocular injection during surgery of the anterior segment of the eye.

SUPPLY

VisiVisc is supplied in 2ml pre-filled glass syringes in pouch packing.

INDICATIONS

A surgical aid (medical device) during surgical procedures involving the anterior chamber of the eye, including extraction of the lens and insertion of intraocular lenses. Maintains the depth of the anterior chamber during the entire surgical procedure and permits greater operative precision without the risk of damaging the endothelium of the cornea or other intraocular tissues.

CONTRAINDICATIONS

No known contraindications when used as instructed.

CHARACTERISTICS

VisiVisc is a medical device for use during surgery involving the anterior chamber of the eye. It has the following unique characteristics:

  • Totally non-antigenic
  • Simple to remove from the anterior chamber
  • Completely transparent
  • Maintains depth of the anterior chamber of the eye & protects the periocular tissues
  • Outstanding rheological properties
  • Does not interfere with the process of cicatrisation
  • Does not contain any proteins likely to cause inflammatory reactions and/or foreign body reactions
  • Does not require refrigeration or particular storage conditions
WARNINGS & PRECAUTIONS

Check integrity of the packaging before use to ensure the product has remained sterile. The cannula and syringe are for single intraocular use only. The quantity injected into the anterior chamber of the eye must be adjusted according to the volume of the aqueous humour and the anatomical structure to be protected. Remove all product by irrigation and/or aspiration at the end of the procedure—mechanical blockage of drainage at the trabecular level may cause a transient increase in intraocular pressure after surgery. All post-operative inflammatory reactions (iritis, hypopyon, uveitis) are inherent in surgical procedures involving the anterior chamber of the eye, and no relationship with the product has been established.

PROPERTIES

Molecular Weight: 80,000 daltons; Dynamic Viscosity: 5,000 cps (± 500 cps); pH: 7.3; Osmolarity: 350 mOSM/kg